Véronique Birault

688 total citations
15 papers, 476 citations indexed

About

Véronique Birault is a scholar working on Molecular Biology, Organic Chemistry and Astronomy and Astrophysics. According to data from OpenAlex, Véronique Birault has authored 15 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Astronomy and Astrophysics. Recurrent topics in Véronique Birault's work include Cystic Fibrosis Research Advances (3 papers), Origins and Evolution of Life (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Véronique Birault is often cited by papers focused on Cystic Fibrosis Research Advances (3 papers), Origins and Evolution of Life (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Véronique Birault collaborates with scholars based in United Kingdom, France and Canada. Véronique Birault's co-authors include Anton M. Jetten, Yukimasa Takeda, Raja Jothi, Thomas Ziegler, Gianluca Pozzi, Yôichi Nakatani, Guy Ourisson, David Y. Thomas, John W. Hanrahan and Roberto Solari and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.

In The Last Decade

Véronique Birault

15 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Birault United Kingdom 13 186 110 88 77 61 15 476
Uwe Klein United States 12 625 3.4× 71 0.6× 37 0.4× 55 0.7× 127 2.1× 18 1.0k
Akifumi Kato Japan 11 176 0.9× 18 0.2× 46 0.5× 15 0.2× 94 1.5× 22 539
Daijiro Hagiwara Japan 13 384 2.1× 137 1.2× 196 2.2× 8 0.1× 74 1.2× 33 806
Vassiliki Magafa Greece 13 299 1.6× 68 0.6× 63 0.7× 23 0.3× 46 0.8× 46 504
Joel Karpiak United States 13 729 3.9× 153 1.4× 59 0.7× 12 0.2× 103 1.7× 14 991
Angelika Krebs Austria 14 368 2.0× 58 0.5× 17 0.2× 7 0.1× 36 0.6× 22 615
Kazushi Morimoto Japan 15 280 1.5× 94 0.9× 99 1.1× 6 0.1× 55 0.9× 37 635
Lars‐Ole Gerlach Denmark 11 478 2.6× 235 2.1× 62 0.7× 214 2.8× 176 2.9× 14 1.0k
Scott Cosmi United States 17 168 0.9× 33 0.3× 82 0.9× 40 0.5× 19 0.3× 23 582
Anne Wijkhuisen France 13 278 1.5× 59 0.5× 90 1.0× 18 0.2× 67 1.1× 33 559

Countries citing papers authored by Véronique Birault

Since Specialization
Citations

This map shows the geographic impact of Véronique Birault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Birault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Birault more than expected).

Fields of papers citing papers by Véronique Birault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Birault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Birault. The network helps show where Véronique Birault may publish in the future.

Co-authorship network of co-authors of Véronique Birault

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Birault. A scholar is included among the top collaborators of Véronique Birault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Birault. Véronique Birault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Carlile, Graeme W., Qi Yang, Elizabeth Matthes, et al.. (2022). The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway. Scientific Reports. 12(1). 4595–4595. 8 indexed citations
2.
Vukmanovic‐Stejic, Milica, Emma S. Chambers, Mayte Suárez‐Fariñas, et al.. (2017). Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation. Journal of Allergy and Clinical Immunology. 142(3). 844–856. 79 indexed citations
3.
Smith, Susan, Yukimasa Takeda, Thi Tho Bui, et al.. (2016). Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin. PLoS ONE. 11(2). e0147979–e0147979. 58 indexed citations
4.
Carlile, Graeme W., Renaud Robert, Elizabeth Matthes, et al.. (2016). Latonduine Analogs Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity. Molecular Pharmacology. 90(2). 65–79. 23 indexed citations
5.
Birault, Véronique, Roberto Solari, John W. Hanrahan, & David Y. Thomas. (2013). Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis. Current Opinion in Chemical Biology. 17(3). 353–360. 27 indexed citations
6.
Takeda, Yukimasa, Raja Jothi, Véronique Birault, & Anton M. Jetten. (2012). RORγ directly regulates the circadian expression of clock genes and downstream targets in vivo. Nucleic Acids Research. 40(17). 8519–8535. 115 indexed citations
7.
Bar, Grégory, Paul Edwards, Reginald Brys, et al.. (2012). Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 22(6). 2266–2270. 12 indexed citations
8.
Birault, Véronique, et al.. (2006). Bringing Kinases Into Focus: Efficient Drug Design Through the Use of Chemogenomic Toolkits. Current Medicinal Chemistry. 13(15). 1735–1748. 12 indexed citations
9.
Birault, Véronique, et al.. (2003). Synthesis and Evaluation as Glycosidase Inhibitors of Carbasugar‐Derived Spirodiaziridines, Spirodiazirines, and Spiroaziridines. Helvetica Chimica Acta. 86(6). 2210–2227. 19 indexed citations
10.
Birault, Véronique, Gianluca Pozzi, Niklas Plobeck, et al.. (1996). Di(polyprenyl) Phosphates as Models for Primitive Membrane Constituents: Synthesis and Phase Properties. Chemistry - A European Journal. 2(7). 789–799. 18 indexed citations
11.
Pozzi, Gianluca, Véronique Birault, Birgit Werner, et al.. (1996). Einkettige Polyprenylphosphate bilden primitive Membranen. Angewandte Chemie. 108(2). 190–192. 5 indexed citations
12.
Pozzi, Gianluca, Véronique Birault, Birgit Werner, et al.. (1996). Single‐Chain Polyprenyl Phosphates Form “Primitive” Membranes. Angewandte Chemie International Edition in English. 35(2). 177–180. 47 indexed citations
13.
Kamino, Ayumi, Katsuhiko Ariga, Toyoki Kunitake, et al.. (1995). Reinforcing effect of polyterpenoids on polyprenyl phosphate monolayers. Colloids and Surfaces A Physicochemical and Engineering Aspects. 103(3). 183–194. 14 indexed citations
15.
Ziegler, Thomas, et al.. (1992). Convenient Synthesis of 4,6-O-Pyruvate Acetal Containing Glycosides via Tetraisopropyldisiloxanediyl Protected Sugars. Synthesis. 1992(10). 1013–1017. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026